Showing posts with label
Diversification in biotech
.
Show all posts
Showing posts with label
Diversification in biotech
.
Show all posts
Tuesday, September 17, 2024
We bought shares of Royalty Pharma plc (NASDAQ: RPRX) to both earn Alpha and as a stable anchor stock!
›
The compelling reasons that led us to buy shares of Royalty Pharma plc (NASDAQ: RPRX) are related to the company's unique business mo...
›
Home
View web version
